Skip to main content

Table 1 Median PKG Symptom Scores and Proportion of Median Scores above Treatment Target Values

From: Objective measurement in Parkinson’s disease: a descriptive analysis of Parkinson’s symptom scores from a large population of patients across the world using the Personal KinetiGraph®

Top 7 PKG Countries; All (n, % of total PKGs)

Median BKS*

Median DKS*

Median PTT*

Median PTI*

As % of country’s PKGs

BKS > 25

DKS > 9

PTT > 1%

PTI > 10%

Australia (n = 8506, 31%)

25.8

1.8

1.2%

6.6%

51.8%

9.5%

53.3%

35.7%

UK (n = 5614, 20%)

26.5

1.8

1.3%

6.6%

55.5%

11.5%

54.7%

36.0%

USA (n = 4729, 17%)

27.5

1.2

1.9%

8.0%

61.2%

5.4%

65.1%

42.1%

Sweden (n = 2782, 10%)

25.0

2.3

1.1%

5.6%

48.0%

14.7%

50.8%

29.5%

Germany (n = 2070, 7%)

26.7

1.6

1.0%

6.9%

56.6%

8.5%

48.4%

36.3%

Netherlands (n = 1641, 6%)

26.0

1.9

1.0%

6.4%

52.4%

9.6%

48.0%

34.1%

France (n = 770, 3%)

24.6

2.8

0.8%

6.7%

46.4%

14.8%

45.1%

35.3%

All Countries (n = 27,834, 100%)

26.2

1.7

1.2%

6.8%

54.2%

9.9%

54.2%

36.6%

  1. *p < 0.0001 for any difference among regions for all four objective symptom scores (BKS, DKS, PTT, and PTI)
  2. BKS Bradykinesia Score, DKS dyskinesia score, PTT percent time in tremor, PTI percent time immobile